BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  ORYZON Strengthens Vafidemstat Patent Portfolio With U.S. Notice of Allowance

  March 25, 2026

   · 

  7 min read
• Press Releases

  LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company

  March 25, 2026

   · 

  9 min read
• Press Releases

  ProQR to Host Virtual Investor and Analyst Event Highlighting Pipeline on April 8, 2026

  March 25, 2026

   · 

  5 min read
• Press Releases

  AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program

  March 25, 2026

   · 

  4 min read
• Press Releases

  Lobe Sciences Ltd. Reports Improved Financial Position and Strategic Update

  March 25, 2026

   · 

  8 min read
• Press Releases

  New Report Highlights Impact of Drug Shortages on People Living with Arthritis Across Canada

  March 25, 2026

   · 

  2 min read
• Press Releases

  ProMIS Neurosciences Announces Full Year 2025 Financial Results and Provides Corporate Highlights

  March 25, 2026

   · 

  15 min read
• Press Releases

  Kalohexis Announces Publication in Frontiers in Endocrinology Defining Design Criteria for Next-Generation Melanocortin Drugs for General Obesity

  March 25, 2026

   · 

  4 min read
• Press Releases

  KalVista Pharmaceuticals Reports Eight Months Fiscal Year 2025 Financial Results and Provides Corporate Update

  March 25, 2026

   · 

  8 min read
• Press Releases

  Nasus Pharma Advances NS002 Towards Pivotal Study Following Positive Phase 2; Reports Annual Results and Provides Business Update

  March 25, 2026

   · 

  7 min read